Enalapril Vs Labetanol For Management Of Postpartum Hypertension.

Enalapril vs Labetanol for management of post partum hypertension in ISTH, single blind randomized controlled trial of effectiveness

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202401918251128

Enrollment

134

Registered

2024-01-15

Start date

2023-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Partum Hypertension

Interventions

INTENTION TO TREAT

Enalapril

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: WOMEN AGED 18 YEAR OR GREATER PRESENCE OF POST PARTUM HYPERTENTION POST DELIVERY BOOKED OR UNBOOKED PATIENTS PATIENTS WITH CHRONIC HYPERTENTION IN PREGNANCY PIH AND PRECLAMSIA

Exclusion criteria

Exclusion criteria: PATIENTS ON 2 OR MORE ANTI HYPERTENSIVE DURING PREGNANCY ECLAMPTIC PATIENTS PATIENTS WITH RENAL DISEASES PATIENTS WITH CADIAC DISEASES PATIENTS WHO ARE ALERGIC TO ENALAPRIL OR LABETALOL

Design outcomes

Primary

Measure	Time frame
Reduction in the mean systolic and diastolic blood pressure	—

Secondary

Measure	Time frame
Tolerability and side effect profile of enalapril versus Labetalol	—

Countries

Nigeria

Contacts

Public ContactYemihan Ogbetere

ISTH HIREC Administrator and Consultant Public Health Physician

yemihanogbetere@gmail.com+2348030770741

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026